Gastrointestinal Cancer News

Multimodal prehabilitation reduced the incidence of severe postoperative complications and enhanced functional recovery among patients who underwent elective resection of non-metastasized colorectal cancer, according to data.

As many as half of cancer-signaling proteins once thought to be resistant to drug treatment due to lack of targetability may, in fact, be treatable, a study conducted at Perelman School of Medicine at the University of Pennsylvania showed.

Receipt of perichemotherapy antibiotics correlated with improved survival in patients with metastatic pancreatic ductal adenocarcinoma treated with gemcitabine, but not fluorouracil, according to results in JAMA Network Open.

Delirium appeared associated with higher ICU and hospital mortality, as well as increased length of stay, among critically ill patients with cancer, according to data published in JCO Oncology Practice.

In a phase 1 trial of mistletoe extract for patients with cancer, researchers at Johns Hopkins Kimmel Cancer Center found the therapy to not only be safe but also potentially beneficial to quality of life.

Elizabeth M. Jaffee, MD, will receive this year’s AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.

Partners of colorectal cancer survivors experienced long-term financial toxicity associated with worse health-related quality of life, according to results of a survey study published in JAMA Network Open.

A prognostic study validated the use of an artificial intelligence-derived tumor adipose feature, which may aid risk stratification of colon cancer and provide prognostic value when integrated into practice, according to study results.

Laparoscopy-assisted distal gastrectomy with D2 lymph node dissection was noninferior to open distal gastrectomy in patients with locally advanced gastric cancer, according to 5-year follow-up data published in JAMA Surgery.

Despite a low likelihood of finding advanced polyps or colorectal cancer, more than 85% of older patients with a history of polyps were advised to return for surveillance colonoscopy, regardless of life expectancy or current results.